4.5 Review

The Bionas technology for anticancer drug screening

期刊

EXPERT OPINION ON DRUG DISCOVERY
卷 4, 期 7, 页码 785-797

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1517/17460440903018840

关键词

cancer cells; cell adhesion; cell metabolism; cell respiration; cell sensor; cytotoxicity; label-free assay; tumor slices

资金

  1. Federal Ministry of Education and Research (BMBF Berlin, 1999-2005)
  2. University of Saarland (1998-2008)
  3. Lilly Deutschland GmbH
  4. Saar Union Savings Bank

向作者/读者索取更多资源

Background: The Bionas 2500 (R) analyzing system is an advanced label-free technology using a cell-based multi-sensor array, which is commercially available. Data on metabolism, respiration, adhesion, cell proliferation and cell death rates, as well as ligand-receptor interactions (multi-parametric) can be acquired and statistically evaluated. Noteworthy is the possibility of analyzing later after effects and/or recovery after drug treatment. In addition, Bionas supports all conceivable drug application modes (one, two or more drugs). Specimens for drug screening with Bionas consist of human permanent cell lines, primary cell cultures as well as 'tumor slices' obtained from biopsies and surgery material. Objective/methods: Examples of measurements are presented and discussed. Conclusion: Although drug throughput is modest, the high quality of the information allows in-depth evaluation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据